Hence, the study demonstrates that miR-193b is an oncogene that promotes cell growth by directly targeting SMAD3 and restricting the tumour-suppressive effects of SMAD3 through p21 down-regulation in GBM [80]. The gene discussed is SMAD3; the disease is glioblastoma.